<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/496F5A5B-C3AD-4E0D-A874-F51C24C2B878"><gtr:id>496F5A5B-C3AD-4E0D-A874-F51C24C2B878</gtr:id><gtr:name>Tokyo Institute of Technology</gtr:name><gtr:address><gtr:line1>2-12-1 Ookayama</gtr:line1><gtr:line2>Meguro-ku</gtr:line2><gtr:line4>Tokyo 152-8550</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Pharmacology</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/496F5A5B-C3AD-4E0D-A874-F51C24C2B878"><gtr:id>496F5A5B-C3AD-4E0D-A874-F51C24C2B878</gtr:id><gtr:name>Tokyo Institute of Technology</gtr:name><gtr:address><gtr:line1>2-12-1 Ookayama</gtr:line1><gtr:line2>Meguro-ku</gtr:line2><gtr:line4>Tokyo 152-8550</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/DCB0A98B-0396-4D46-B265-69C4DD448BA7"><gtr:id>DCB0A98B-0396-4D46-B265-69C4DD448BA7</gtr:id><gtr:firstName>Hendrik Willem</gtr:firstName><gtr:surname>van Veen</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FK017713%2F1"><gtr:id>49471F08-0727-4775-A75F-CA5EE65242F9</gtr:id><gtr:title>Transport mechanism of a multidrug transporter from Vibrio cholerae</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/K017713/1</gtr:grantReference><gtr:abstractText>We live in a time in which drug resistance has become a global threat to health care and in which concerns about the lack of effective antimicrobial drugs are communicated with increasing frequency. One very powerful mechanism of drug resistance in microorganisms is based on the transport of the drugs out of the cell by pump proteins that can recognise an extraordinarily broad range of antibiotics and disinfectants. In this project, we ask a few simple questions about these proteins: how do they bind substrates and how do they use cell's energy to pump? Answers to these questions will allow us to generate inhibitors of these pump proteins and new antibiotics that can bypass drug pumping.</gtr:abstractText><gtr:technicalSummary>In the past decade, crystal structures have been determined for multidrug transporters belonging to four families. However, the structure of members of the final family, that of multidrug and toxic compound extrusion (MATE) proteins, has only recently been determined. MATE transporters may be last in the list of crystallised multidrug transporters, but they are certainly not the least. They are present in all kingdoms of life and, in addition to their role in microbial drug resistance, they are essential for the detoxification of metabolic products in plants and for the excretion of toxins by the liver and kidney in mammals. Over the past decade, crystallographic evidence has been obtained supporting the general concept of alternating access for a variety of membrane transporters, demonstrating that this mechanism has been evolutionarily conserved. However, the structural details and biochemical reactions underlying the necessary conformational changes in multidrug transporters are only partly understood. This is particularly true for MATE transporters, for which very few studies on structure-function relationships have been published to date. In this project we will study the mechanism by which the MATE transporter NorM from Vibrio cholerae mediates antiport between coupling ions and substrates. The involvement of Na(+) in the transport reaction of NorM offers a unique opportunity compared to 'conventional' H(+)/drug antiporters to study the antiport reaction from the perspective of the transported substrate AND coupling ion, as Na(+) can be detected by using radioactive 22Na+. We will identify catalytic residues in NorM that are important for interactions with Na(+) and substrates, and we will challenge NorM's mechanism by relocating these residues to various positions in binding pockets. In this way, we will unravel details of the mechanism of transport and identify possible routes by which multidrug transporters can be inhibited.</gtr:technicalSummary><gtr:potentialImpactText>The development and spread of multidrug resistance in microorganisms impairs the chemotherapeutic treatment of microbial infections in humans and animals. Our aim is to study the fundamental mechanisms of one member of the MATE (the multidrug and toxic compound extrusion) family that can confer drug resistance on the cell by mediating the transport of multiple drugs away from their intracellular targets. The activities and mechanisms established will be relevant for other bacterial, plant and mammalian members in this family as well as multidrug transporters from other protein families in eubacterial and eukaryotic cells.

Our research has clear social and economic impact as increased knowledge of the biochemical mechanism of multidrug transporters will generate new avenues for modulation of their activity in a clinical setting. This will offer considerable potential for modulator development programs in pharmaceutical industries and commercial institutes. These modulators can rejuvenate existing antimicrobials when target cells are resistant. This research might also lead to the development of new antibiotics that can bypass drug pumping.</gtr:potentialImpactText><gtr:fund><gtr:end>2017-08-17</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2014-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>277022</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Dr Julian Parkhill</gtr:description><gtr:id>1FA6F07F-413E-4749-A542-D019608E11B4</gtr:id><gtr:impact>Collaboration is ongoing</gtr:impact><gtr:partnerContribution>Collaborator provides genomic sequencing and sequence analyses</gtr:partnerContribution><gtr:piContribution>We provide cell lines and mutants</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tokyo Institute of Technology</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:department>Department of Life Sciences</gtr:department><gtr:description>Collaboration with Prof Murakami (Japan)</gtr:description><gtr:id>42F8D38A-F6F5-4ED3-94AF-881BA5F11C37</gtr:id><gtr:impact>Co-author on publication</gtr:impact><gtr:partnerContribution>Collagues in Japan provided protein structures</gtr:partnerContribution><gtr:piContribution>We assisted with experimental work and interpretations of protein structures generated in Tokyo</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Postdoc talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>61C11C64-7A01-43D2-A3E2-D29F961FBCC3</gtr:id><gtr:impact>BBSRC-funded postdoc gave take in conference on Antbiotic Resistance in Birmingham</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation by BBSRC-funded postdoc</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EF1BDD13-8711-46C3-BAE1-FAB0600864D0</gtr:id><gtr:impact>Poster presentation Dr Asha Nair at Gordon Research Conference on Membrane Proteins in Lucca (Barga), Italy</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited reviewer of Longitude Prize 2014 on Antibiotics</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F8A624B5-6DE4-473A-BDF2-AE646A84D517</gtr:id><gtr:impact>Invited reviewer for second-phase prototype text and set-up of the Longitude Challenge Prize</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.nesta.org.uk/sites/default/files/longitude-paper-antibiotics-open-review.pdf</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited talk 8th Annual SFB35 Symposium in Vienna (Austria)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>260C4D5D-EF0F-48A8-81E2-E8001E41EFA9</gtr:id><gtr:impact>Invited talk</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Study participants or study members</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited talk at Gordon Research Conference on Multidrug Efflux (Italy)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0AFD5767-6A88-4C08-87EE-36634230F007</gtr:id><gtr:impact>Invited talk</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Study participants or study members</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Organising Chair of Antibiotic Resistance Conference by RSC and BSAC</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>439FC592-3380-4D65-9194-9325054126E4</gtr:id><gtr:impact>Organising Chair of a 2-day Antbiotic Resistance Mechanisms Workshop of the Bristish Society for Antimicrobial Chemotherapy (BSAC) in collaboration with the Royal Society of Chemistry (RSC)</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.bsac.org.uk/wp-content/uploads/2014/12/ARM-2015-Programme-Registration-Form-after-25-Sept.pdf</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited talk at University of Warwick</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>66D73637-E8A1-4D46-9FED-E10D38BBCAC5</gtr:id><gtr:impact>Invited talk</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Study participants or study members</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Radio Interview Naked Scientists &quot;When drugs don't work&quot;</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6BCC6DB5-8E77-41E1-B4F4-FECCA27F1725</gtr:id><gtr:impact>Invited to participate in a BBC Radio Broadcast by the Naked Scientists on 6 December 2016</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.thenakedscientists.com/podcasts/naked-scientists/when-drugs-dont-work</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited talk Antibiotic Resistance &amp; Antbiotic Alternatives, O2 London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B2D133CF-79A0-4084-844C-BF5B154A3F1A</gtr:id><gtr:impact>Invited talk</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Our currently published papers contribute to the awareness of the role of multidrug efflux pumps in microbial drug resistance.</gtr:description><gtr:firstYearOfImpact>2014</gtr:firstYearOfImpact><gtr:id>5D574333-C52D-4F83-BBD9-605E87D72792</gtr:id><gtr:impactTypes><gtr:impactType>Societal,Policy &amp; public services</gtr:impactType></gtr:impactTypes><gtr:sector>Chemicals,Education,Environment,Healthcare,Government, Democracy and Justice,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>Membrane transporters belonging to the multidrug and toxic compound extrusion (MATE) family mediate the efflux of unrelated pharmaceuticals from the cell's interior in organisms ranging from bacteria to human. These proteins are thought to fall into two classes that couple substrate efflux to the influx of either Na+ or H+. We studied the energetics of drug extrusion by NorM from Vibrio cholerae in proteoliposomes in which purified NorM protein was functionally reconstituted in an inside-out orientation. We establish that NorM simultaneously couples to the sodium-motive force and proton-motive force, and biochemically identify protein regions and residues that play important roles in Na+ or H+ binding. As the positions of protons are not available in current medium and high-resolution crystal structures of MATE transporters, our findings add a previously unrecognized parameter to mechanistic models based of these structures.</gtr:description><gtr:exploitationPathways>Our data will affect mechanistic models on MATE transporters that will be generated by others in MATE research, and have relevance for the general field of transport.</gtr:exploitationPathways><gtr:id>2C362C94-AF6A-4D8E-8563-E891CB2782FC</gtr:id><gtr:sectors><gtr:sector>Education,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>https://globalmedicaldiscovery.com/key-scientific-articles/multidrug-transport-protein-norm-vibrio-cholerae-simultaneously-couples-sodium-proton-motiveforce/</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FA3E0CCC-CED2-421F-9EE3-08108AE73F98"><gtr:id>FA3E0CCC-CED2-421F-9EE3-08108AE73F98</gtr:id><gtr:title>Assembly and operation of bacterial tripartite multidrug efflux pumps.</gtr:title><gtr:parentPublicationTitle>Trends in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0425a67b04dc61fede52967363081e23"><gtr:id>0425a67b04dc61fede52967363081e23</gtr:id><gtr:otherNames>Du D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0966-842X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5CACA95F-F464-4CC8-8B9D-C88DEC43C28E"><gtr:id>5CACA95F-F464-4CC8-8B9D-C88DEC43C28E</gtr:id><gtr:title>?-Lactam selectivity of multidrug transporters AcrB and AcrD resides in the proximal binding pocket.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a96a792cc85f40a1a3a9af45e9e45431"><gtr:id>a96a792cc85f40a1a3a9af45e9e45431</gtr:id><gtr:otherNames>Kobayashi N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FD49E619-2706-4C7C-82D2-E4C12F118B67"><gtr:id>FD49E619-2706-4C7C-82D2-E4C12F118B67</gtr:id><gtr:title>Hoechst 33342 Is a Hidden &amp;quot;Janus&amp;quot; amongst Substrates for the Multidrug Efflux Pump LmrP.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b5db21ba429e5594e1e1170aa1a9b4fa"><gtr:id>b5db21ba429e5594e1e1170aa1a9b4fa</gtr:id><gtr:otherNames>Neuberger A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7F46CBBC-EAFA-43E3-9696-A46FC5203A94"><gtr:id>7F46CBBC-EAFA-43E3-9696-A46FC5203A94</gtr:id><gtr:title>Relocation of active site carboxylates in major facilitator superfamily multidrug transporter LmrP reveals plasticity in proton interactions.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8eb16610275274c5056d0cc83c2d04de"><gtr:id>8eb16610275274c5056d0cc83c2d04de</gtr:id><gtr:otherNames>Nair AV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5C9BDA4A-8880-48FB-854E-71CA52FE6093"><gtr:id>5C9BDA4A-8880-48FB-854E-71CA52FE6093</gtr:id><gtr:title>Multidrug transport protein norM from vibrio cholerae simultaneously couples to sodium- and proton-motive force.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cc3ff549a4bfd0121f0f968b71d23ee9"><gtr:id>cc3ff549a4bfd0121f0f968b71d23ee9</gtr:id><gtr:otherNames>Jin Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B23519A4-DE96-47CD-9987-6F1AD61CD155"><gtr:id>B23519A4-DE96-47CD-9987-6F1AD61CD155</gtr:id><gtr:title>Structure, mechanism and cooperation of bacterial multidrug transporters.</gtr:title><gtr:parentPublicationTitle>Current opinion in structural biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0425a67b04dc61fede52967363081e23"><gtr:id>0425a67b04dc61fede52967363081e23</gtr:id><gtr:otherNames>Du D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0959-440X</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/K017713/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>F442B6BE-8B89-4C01-8D3B-E8A4D320B672</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biomolecules &amp; biochemistry</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>6723A70B-A523-40AB-9740-B6AD2A0677B7</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Medical &amp; health interface</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>2607D197-52EE-40CA-A1D5-A46D18C3F97F</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Microbial sciences</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>649031FD-C21E-42D9-AC12-41ACA59CC11C</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biochemistry &amp; physiology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>D22AE401-1C35-4706-A19C-10861ABC82CD</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biological membranes</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>02567418-12CB-462E-9092-530C6E63B359</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Chemical Biology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>E48C802F-8897-4353-910A-09D09331BB82</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Medical science &amp; disease</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>5BA89E2C-27FE-4553-819B-3CE27FC71EC2</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Microbiology</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>